Before the First Cell Divides: AI and the Future of Fertility Care
Signals of TEDAI San Francisco and Kindbody present: Before the First Cell Divides: AI and the Future of Fertility Care
In recognition of National Infertility Awareness Week, this Signals event explores how artificial intelligence is shaping reproductive medicine and what it means for patients’ access to care.
The question is no longer whether AI belongs in fertility treatment. It’s how responsibly it’s built, and what it costs patients when it isn’t. From advanced embryo analysis and AI-enabled clinical documentation to financial navigation tools that help patients manage the real costs of care, these technologies are already being integrated at scale.
Join us for a conversation inside one of the country’s leading fertility clinic networks and the innovations beginning to redefine and expand how fertility care is delivered and accessed.
Opening Signals | 6:30–7:00 pm The Most Human Technology: AI, Fertility, and the Future of Reproductive Care with David Stern, CEO, Kindbody
Conversation | 7:00–8:00 pm The Clinical Frontier: AI in Embryology, Documentation, and the Patient Journey
Melissa Teran, CEO, ALife
Lucy Huang, COO, Cercle.ai
Dr. Amber Cooper, CMO, Kindbody
Simone Aisiks, Head of Partnerships, Heidi
Marily Nika, PhD Gen AI product leader, Google
The evening closes with a rare opportunity: a tour of Kindbody's San Francisco clinic.
Request your invitation today — space is limited.
The event is free, but application is required.